XWELL (XWEL) Growth Rank : 2 (As of Apr. 25, 2024)

View and export this data going back to 2010. Start your Free Trial

What is XWELL Growth Rank?

XWELL has the Growth Rank of 2.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of XWELL's Growth Rank

For the Diagnostics & Research subindustry, XWELL's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XWELL's Growth Rank Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, XWELL's Growth Rank distribution charts can be found below:

* The bar in red indicates where XWELL's Growth Rank falls into.

XWELL Growth Rank Related Terms

Thank you for viewing the detailed overview of XWELL's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

XWELL (XWEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » XWELL Inc (NAS:XWEL) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

254 West 31st Street, 11th Floor, New York, NY, USA, 10001

Website

https://www.xwell.com

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products. Treat is a travel health and wellness brand that offers in-airport spa and wellness medical services. XpresCheck provides Covid-19 screening and diagnostic testing in partnership with the CDC. HyperPointe is a digital healthcare and data analytics relationship company.

Executives

Suzanne A. Scrabis	officer: Chief Financial Officer	C/O XWELL, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Robert Weinstein	director	3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169
Scott R Milford	officer: Chief Executive Officer	C/O TOWN SPORTS INTERNATIONAL, LLC, 5 PENN PLAZA, NEW YORK NY 10001
Bruce Bernstein	director	780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017
Ezra Ernst	officer: See Remarks	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Omar Haynes	officer: VP Treas & Fi & Interim CFO	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Doug Satzman	director, officer: Chief Executive Officer	780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017
James A. Berry	officer: Chief Financial Officer	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Michael Lebowitz	director	780 THIRD AVENUE, 12TH FLOOR, C/O XPRESSPA GROUP, INC., NEW YORK NY 10017
Donald E. Stout	director	780 THIRD AVENUE, 15TH FLOOR, NEW YORK NY 10017
Mistral Spa Holdings, Llc	10 percent owner	C/O MISTRAL CAPITAL MANAGEMENT, LLC, 650 FIFTH AVENUE, 31ST FLOOR, NEW YORK NY 10019
Mistral Capital Management, Llc	10 percent owner	650 FIFTH AVENUE, 31ST FLOOR, NEW YORK NY 10019
Andrew R Heyer	other: Former director and 10% owner	501 MADISON AVENUE, FLOOR 5, NEW YORK NY 10019
Calm.com, Inc.	10 percent owner	140 2ND STREET, THIRD FLOOR, SAN FRANCISCO CA 94105
Edward Jankowski	officer: SVP; CEO of XpresSpa	C/O FORM HOLDINGS CORP., 780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017